Well- interim had 3/11 "responders", so worst case from here is 3/27.. at greater than 50% reduction on standard of care; even 3/27 or 11% is pretty good.. at Ph2b they will have patients on the most effective dose(s) for longer and have a better selected patient population which are more likely to show benefit to this drug combination.. so unless there is a major safety issue (which is very unlikely because they would have to have disclosed it under continuous disclosure) the results we know are already good. if they can achieve at least 6/27 at 50% or greater, ie >22% - I think that is a fantastic result. Shows the first 3 weren't flukes! My 2c+ prediction is only because I have lost some faith that the market will release its full value prior to a licensing deal..
- Forums
- ASX - By Stock
- DXB Share Price
Well- interim had 3/11 "responders", so worst case from here is...
-
- There are more pages in this discussion • 278 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
|
|||||
Last
42.0¢ |
Change
-0.025(5.62%) |
Mkt cap ! $231.2M |
Open | High | Low | Value | Volume |
43.5¢ | 44.0¢ | 41.8¢ | $1.239M | 2.905M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 257588 | 42.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
42.5¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9999 | 0.420 |
5 | 140871 | 0.415 |
9 | 112924 | 0.410 |
4 | 97555 | 0.405 |
13 | 124652 | 0.400 |
Price($) | Vol. | No. |
---|---|---|
0.425 | 10000 | 1 |
0.430 | 107896 | 3 |
0.440 | 20000 | 1 |
0.445 | 100000 | 1 |
0.450 | 83817 | 4 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |